Effect of peptide pools on effector functions of antigen-specific CD8+ T cells

Journal of Immunological Methods

Volumn 342, Issue 1-2, 2009, Pages 33-48

  Suneetha, Pothakamuri Venkata ^a   Schlaphoff, Verena ^a   Wang, Chun ^a   Stegmann, Kerstin Anne ^a   Fytili, Paraskevi ^a   Sarin, Shiv Kumar ^b   Manns, Michael Peter ^a   Cornberg, Markus ^a   Wedemeyer, Heiner ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b G B PANT HOSPITAL   (India)

Author keywords

Overlapping peptides; Programmed death 1; T cell proliferation; T cells

Indexed keywords

CD8 ANTIGEN; CYTOMEGALOVIRUS ANTIGEN PP65; EPITOPE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA A2 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; NONSTRUCTURAL PROTEIN 3; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CYTOKINE RELEASE; CYTOMEGALOVIRUS; EFFECTOR CELL; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS E VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLUENZA VIRUS; LYMPHOCYTE PROLIFERATION; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; DIMETHYL SULFOXIDE; EPITOPES; EPITOPES, T-LYMPHOCYTE; HEPATITIS DELTA VIRUS; HEPATITIS E VIRUS; HLA-A2 ANTIGEN; HUMANS; PEPTIDES;

HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4; ORTHOMYXOVIRIDAE;

EID: 59749101382     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.11.020     Document Type: Article

References (39)

1. Addo M.M., Yu X.G., Rathod A., Cohen D., Eldridge R.L., Strick D., Johnston M.N., Corcoran C., Wurcel A.G., Fitzpatrick C.A., Feeney M.E., Rodriguez W.R., Basgoz N., Draenert R., Stone D.R., Brander C., Goulder P.J., Rosenberg E.S., Altfeld M., and Walker B.D. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77 (2003) 2081
2. Aggarwal R., Shukla R., Jameel S., Agrawal S., Puri P., Gupta V.K., Patil A.P., and Naik S. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J. Viral. Hepat. 14 (2007) 283
3. Agrawal B., Krantz M.J., Reddish M.A., and Longenecker B.M. Rapid induction of primary human CD4+ and CD8+ T cell responses against cancer-associated MUC1 peptide epitopes. Int. Immunol. 10 (1998) 1907
4. Armstrong A.C., Dermime S., Allinson C.G., Bhattacharyya T., Mulryan K., Gonzalez K.R., Stern P.L., and Hawkins R.E. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope. J. Immunol. 168 (2002) 3983
5. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., and Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006) 682
6. Deterding K., Pothakamuri S.V., Schlaphoff V., Hadem J., Metzler F., Bahr M.J., Manns M.P., Cornberg M., and Wedemeyer H. Clearance of Chronic HCV Infection During Acute Delta Hepatitis (2005) doi:10.1007/s15010-007-7204-7
7. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K., Lennon V.A., Celis E., and Chen L. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8 (2002) 793
8. Durso R.J., Andjelic S., Gardner J.P., Margitich D.J., Donovan G.P., Arrigale R.R., Wang X., Maughan M.F., Talarico T.L., Olmsted R.A., Heston W.D., Maddon P.J., and Olson W.C. A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses. Clin. Cancer Res. 13 (2007) 3999
9. Fife B.T., and Bluestone J.A. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev. 224 (2008) 166
10. Freeman G.J., Wherry E.J., Ahmed R., and Sharpe A.H. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203 (2006) 2223
11. Ganusov V.V., Milutinovic D., and De Boer R.J. IL-2 regulates expansion of CD4 T cell populations by affecting cell death: insights from modeling CFSE Data. J. Immunol. 179 (2007) 950
12. Grakoui A., John-Wherry E., Hanson H.L., Walker C., and Ahmed R. Turning on the off switch: regulation of anti-viral T cell responses in the liver by the PD-1/PD-L1 pathway. J. Hepatol. 45 (2006) 468
13. Hilchey S.P., and Bernstein S.H. Use of CFSE to Monitor ex vivo regulatory T-cell suppression of CD4(+) and CD8(+) T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies. Immunol. Invest. 36 (2007) 629
14. Jones N., Eggena M., Baker C., Nghania F., Baliruno D., Mugyenyi P., Ssali F., Barugahare B., and Cao H. Presence of distinct subsets of cytolytic CD8+ T cells in chronic HIV infection. AIDS Res. Hum. Retrovir. 22 (2006) 1007
15. Kumar S., Yan J., Muthumani K., Ramanathan M.P., Yoon H., Pavlakis G.N., Felber B.K., Sidhu M., Boyer J.D., and Weiner D.B. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. DNA Cell Biol. 25 (2006) 383
16. Lauer G.M., Ouchi K., Chung R.T., Nguyen T.N., Day C.L., Purkis D.R., Reiser M., Kim A.Y., Lucas M., Klenerman P., and Walker B.D. Comprehensive analysis of CD8(+) T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J. Virol. 76 (2002) 6104
17. Lauer G.M., Lucas M., Timm J., Ouchi K., Kim A.Y., Day C.L., Schulze Zur Wiesch J., Paranhos-Baccala G., Sheridan I., Casson D.R., Reiser M., Gandhi R.T., Li B., Allen T.M., Chung R.T., Klenerman P., and Walker B.D. Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. J. Virol. 79 (2005) 12979
18. Lee S.T., Liu S., Radvanyi L., Sukhumalchandra P., Molldrem J.J., Wieder E.D., Hwu P., Liu Y.J., Kwak L.W., Lizée G., and Neelapu S.S. A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones. J. Immunol. Methods 331 (2007) 13
19. Li G.F., Wang Y., Zhang Z.S., Wang X.J., Ji M.J., Zhu X., Liu F., Cai X.P., Wu H.W., and Wu G.L. Identification of immunodominant Th1-type T cell epitopes from Schistosoma japonicum 28 kDa glutathione-S-transferase, a vaccine candidate. Acta Biochim. Biophys. Sin. 37 (2005) 751
20. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243 (2000) 147
21. Maecker H.T., Dunn H.S., Suni M.A., Khatamzas E., Pitcher C.J., Bunde T., Persaud N., Trigona W., Fu T.M., Sinclair E., Bredt B.M., McCune J.M., Maino V.C., Kern F., and Picker L.J. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255 (2001) 27
22. Malhotra U., Li F., Nolin J., Allison M., Zhao H., Mullins J.I., Self S., and McElrath M.J. Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection. J. Virol. 81 (2007) 5225
23. McCarthy C., Youde S.J., and Man S. Definition of an HPV18/45 cross-reactive human T-cell epitope after DNA immunisation of HLA-A2/KB transgenic mice. Int. J. Cancer 118 (2006) 2514
24. Omiya R., Buteau C., Kobayashi H., Paya C.V., and Celis E. Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope. J. Immunol. 169 (2002) 2172
25. Petrovas C., Price D.A., Mattapallil J., Ambrozak D.R., Geldmacher C., Cecchinato V., Vaccari M., Tryniszewska E., Gostick E., Roederer M., Douek D.C., Morgan S.H., Davis S.J., Franchini G., and Koup R.A. SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 110 (2007) 928
26. Pillai V., Lee W.M., Thiele D.L., and Karandikar N.J. Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses. J. Viral Hepatitis 14 (2007) 318
27. Reap E.A., Dryga S.A., Morris J., Rivers B., Norberg P.K., Olmsted R.A., and Chulay J.D. Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins. Clin. Vaccine Immunol. 14 (2007) 748
28. Rehermann B., and Naoumov N.V. Immunological techniques in viral hepatitis. J. Hepatol. 46 (2007) 508
29. Rothman A.L., Yamada Y., Jameson J., Cruz J., West K., Green S., and Ennis F.A. Assessment of human CD4+ and CD8+ T lymphocyte responses in experimental viral vaccine studies. Dev. Biol. Stand. 95 (1998) 95
30. Seko Y., Yagita H., Okumura K., Azuma M., and Nagai R. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3. Cardiovasc. Res. 75 (2007) 158
31. Shoker A.S., Murabit M.A., Georges F.F., Qualtierem L.F., Deneer H.G., and Prasad K. Inhibition of human lymphocyte function by organic solvents. Mol. Cell. Biochem. 171 (1997) 49
32. Smith J.G., Liu X., Kaufhold R.M., Clair J., and Caulfield M.J. Development and Validation of a Gamma Interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin. Diagn. Lab. Immunol. 8 (2001) 871
33. Smyk-Pearson S., Tester I.A., Lezotte D., Sasaki A.W., Lewinsohn D.M., and Rosen H.R. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design. J. Infect. Dis. 194 (2006) 454
34. Urbani S., Amadei B., Tola D., Massari M., Schivazappa S., Missale G., and Ferrari C. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 80 (2006) 11398
35. Walton S.M., Gerlinger M., de la Rosa O., Nuber N., Knights A., Gati A., Laumer M., Strauss L., Exner C., Schäfer N., Urosevic M., Dummer R., Tiercy J.M., Mackensen A., Jaeger E., Lévy F., Knuth A., Jäger D., and Zippelius A. Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patients. J. Immunol. 177 (2006) 8212
36. Wedemeyer H., Mizukoshi E., Davis A.R., Bennink J.R., and Rehermann B. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J. Virol. 75 (2001) 11392
37. Wertheimer A.M., Miner C., Lewinsohn D.M., Sasaki A.W., Kaufman E., and Rosen H.R. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 37 (2003) 577
38. Wherry E.J., Ha S.J., Kaech S.M., Haining W.N., Sarkar S., Kalia V., Subramaniam S., Blattman J.N., Barber D.L., and Ahmed R. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27 (2007) 670
39. Wiegand J., Cornberg M., Aslan N., Schlaphoff V., Sarrazin C., Kubitschke A., Buggisch P., Ciner A., Jaeckel E., Manns M.P., and Wedemeyer H. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C. Antivir. Ther. 12 (2007) 303